Compare head to head
The comparison grid we would build for a client. Best score in each row is underlined — but read the category first, because comparing a companion vendor to a full-service clinic will mislead you.
Select up to 3 vendors
1 selected
| Vendor | 6.6 Noom Med Consumer-brand clinical |
|---|---|
| Category | Consumer-brand clinical |
| Scores | |
| Clinical rigor | 6.2 |
| Outcomes evidence | 5.9 |
| Cost control | 6.0 |
| Data & reporting | 6.4 |
| Integration | 7.1 |
| Member experience | 8.8 |
| Commercial | |
| PMPM range | $28–$62 |
| Pricing model | Per-enrolled-member monthly, with consumer-style tiering |
| Performance guarantees | Engagement guarantees only |
| Minimum lives | 250 |
| Term | 12 months |
| Termination notice | 30 days |
| Clinical | |
| Prescribes | Yes |
| Step therapy | No |
| Prior authorization | No |
| BMI threshold | BMI ≥ 27 |
| Off-ramp protocol | Behavioral maintenance track carried over from the consumer product |
| Evidence | |
| Evidence level | Peer-reviewed RCT |
| Follow-up | 68 weeks, well beyond the end of the core programme |
| Assessment | |
| Best for | Employers prioritizing reach and enrollment over cost control, or running a first pilot with minimal commitment. |
| Watch out | High enrollment is a cost risk, not just a win. Model what happens if uptake lands at the top of Noom's range. |
| Verdict | Excellent at getting members in the door, weakest here at managing what happens after. Reasonable as a bounded pilot; hard to defend as your primary cost-control strategy. |